ZA9710255B - Crystals of benzimidazole derivatives and their production - Google Patents

Crystals of benzimidazole derivatives and their production

Info

Publication number
ZA9710255B
ZA9710255B ZA9710255A ZA9710255A ZA9710255B ZA 9710255 B ZA9710255 B ZA 9710255B ZA 9710255 A ZA9710255 A ZA 9710255A ZA 9710255 A ZA9710255 A ZA 9710255A ZA 9710255 B ZA9710255 B ZA 9710255B
Authority
ZA
South Africa
Prior art keywords
substituted
optionally
crystals
production
benzimidazole derivatives
Prior art date
Application number
ZA9710255A
Other languages
English (en)
Inventor
Masazasu Kato
Toru Ishida
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17920069&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA9710255(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ZA9710255B publication Critical patent/ZA9710255B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA9710255A 1996-11-14 1997-11-13 Crystals of benzimidazole derivatives and their production ZA9710255B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30336196 1996-11-14

Publications (1)

Publication Number Publication Date
ZA9710255B true ZA9710255B (en) 1999-05-13

Family

ID=17920069

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9710255A ZA9710255B (en) 1996-11-14 1997-11-13 Crystals of benzimidazole derivatives and their production

Country Status (18)

Country Link
US (1) US6002011A (de)
EP (1) EP0944617B1 (de)
KR (1) KR100519576B1 (de)
CN (2) CN100355749C (de)
AT (1) ATE240314T1 (de)
AU (1) AU731776B2 (de)
CA (1) CA2269053C (de)
DE (1) DE69722027T2 (de)
DK (1) DK0944617T3 (de)
ES (1) ES2199356T3 (de)
ID (1) ID21547A (de)
IL (1) IL129724A (de)
NZ (1) NZ335145A (de)
PT (1) PT944617E (de)
TR (1) TR199901055T2 (de)
TW (1) TW385306B (de)
WO (1) WO1998021201A1 (de)
ZA (1) ZA9710255B (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW385306B (en) * 1996-11-14 2000-03-21 Takeda Chemical Industries Ltd Method for producing crystals of benzimidazole derivatives
UA72748C2 (en) 1998-11-10 2005-04-15 Astrazeneca Ab A novel crystalline form of omeprazole
IL142703A (en) 1998-11-10 2006-04-10 Astrazeneca Ab Crystalline form of omeprazole
JP3926936B2 (ja) 1998-11-16 2007-06-06 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホキシド誘導体・アセトン錯体およびその製造法
WO2000045851A2 (de) * 1999-02-04 2000-08-10 Bullerdiek Joern Mittel zur prävention und/oder behandlung einer gewebeveränderung mesenchymalen ursprungs
US7110444B1 (en) 1999-08-04 2006-09-19 Parkervision, Inc. Wireless local area network (WLAN) using universal frequency translation technology including multi-phase embodiments and circuit implementations
TWI289557B (en) * 1999-06-17 2007-11-11 Takeda Chemical Industries Ltd A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
PL333847A1 (en) * 1999-06-18 2001-01-02 Inst Farmaceutyczny Crystalline forms of lansoprozole and method of obtaining lansoprazole in pharmacologically advanthageous crystalline form
AU5705700A (en) 1999-06-30 2001-01-22 Takeda Chemical Industries Ltd. Crystals of benzimidazole compounds
EP1293507B1 (de) * 2000-05-15 2007-11-28 Takeda Pharmaceutical Company Limited Verfahren zur herstellung eines kristalls
CA2417311C (en) 2000-08-04 2012-07-10 Takeda Chemical Industries, Ltd. Crystalline alkali metal salts of lansoprazole and their production and use
CA2419067C (en) 2000-08-18 2008-12-23 Takeda Chemical Industries, Ltd. Injectable composition comprising benzimidazole compound and strong alkali
KR20100002278A (ko) 2000-12-01 2010-01-06 다케다 야쿠힌 고교 가부시키가이샤 (ｒ)- 또는 (ｓ)-란소프라졸의 결정
DE10140492A1 (de) 2001-08-17 2003-08-14 Gruenenthal Gmbh Hydrate von gegebenenfalls substituierten 2-(2-Pyridinyl)methylthio-1H-benzimidazolen und Verfahren zu ihrer Herstellung
US8105626B2 (en) 2001-10-17 2012-01-31 Takeda Pharmaceutical Company Limited Granules containing acid-unstable chemical in large amount
MXPA04007995A (es) * 2002-02-19 2004-11-26 Teva Pharma Desolvatacion de solvatos de hemicalcio de atorvastatina.
AU2003224779A1 (en) * 2002-03-27 2003-10-13 Teva Pharmaceutical Industries Ltd. Lansoprazole polymorphs and processes for preparation thereof
KR100873419B1 (ko) * 2002-06-18 2008-12-11 페어차일드코리아반도체 주식회사 높은 항복 전압, 낮은 온 저항 및 작은 스위칭 손실을갖는 전력용 반도체 소자
TW200410955A (en) 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
ATE375338T1 (de) * 2002-08-21 2007-10-15 Teva Pharma Verfahren zur aufreinigung von lanzoprazol
EP1764364A1 (de) * 2002-08-21 2007-03-21 Teva Pharmaceutical Industries Ltd Eine Methode zur Reinigung von Lansoprazol
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
EP1552833B1 (de) 2002-10-16 2016-12-28 Takeda Pharmaceutical Company Limited Herstellung eines amorphen, optisch aktiven Isomers von Lansoprazol
EP1743893A1 (de) 2002-11-18 2007-01-17 Teva Pharmaceutical Industries Ltd. Stabiles Lansoprazol, enthaltend mehr als 500 ppm bis zu 3000 ppm Wasser und mehr als 200 ppm bis zu 5000 ppm Alkohol
EP1465890B1 (de) * 2002-11-18 2007-04-04 Teva Pharmaceutical Industries Ltd. Stabiles lansoprazol, enthaltend mehr als 500 ppm bis zu 3000 ppm wasser und mehr als 200 ppm bis zu 5000 ppm alkohol
US7678816B2 (en) * 2003-02-05 2010-03-16 Teva Pharmaceutical Industries Ltd. Method of stabilizing lansoprazole
US7005732B2 (en) * 2003-10-21 2006-02-28 Honeywell International Inc. Methods and systems for providing MEMS devices with a top cap and upper sense plate
TW200526268A (en) * 2003-12-17 2005-08-16 Takeda Pharmaceutical Injectable composition
SE0400410D0 (sv) * 2004-02-20 2004-02-20 Astrazeneca Ab New compounds
EP1768668A2 (de) 2004-06-16 2007-04-04 Tap Pharmaceutical Products, Inc. Multi-ppi-dosierform
EP1790647B1 (de) 2004-09-13 2013-05-08 Takeda Pharmaceutical Company Limited Verfahren zur herstellung von oxidierter verbindung
EP1681056A1 (de) * 2005-01-14 2006-07-19 Krka Tovarna Zdravil, D.D., Novo Mesto Verfahren zur Herstellung von Lansoprazol
EP2275088B2 (de) 2005-02-25 2018-09-26 Takeda Pharmaceutical Company Limited Verfahren zur Granulatherstellung
WO2006132217A1 (ja) * 2005-06-07 2006-12-14 Takeda Pharmaceutical Company Limited ベンズイミダゾール化合物の塩の結晶
EP1903039A4 (de) * 2005-06-13 2010-09-22 Takeda Pharmaceutical Injektion
WO2007074909A1 (ja) 2005-12-28 2007-07-05 Takeda Pharmaceutical Company Limited 放出制御固形製剤
KR100758600B1 (ko) * 2006-01-05 2007-09-13 주식회사 대웅제약 란소프라졸 결정형 ａ의 제조방법
WO2008035189A1 (en) * 2006-09-22 2008-03-27 Orchid Chemicals & Pharmaceuticals Limited A method for the purification of lansoprazole
WO2008068767A2 (en) * 2006-12-07 2008-06-12 Hetero Drugs Limited A novel crystalline form of lansoprazole
ITMI20062481A1 (it) * 2006-12-22 2008-06-23 Recordati Chem Pharm Processo per la preparazione di lansoprazolo forma i microcristallino
JP5366558B2 (ja) 2006-12-28 2013-12-11 武田薬品工業株式会社 口腔内崩壊性固形製剤
EP2573082A1 (de) * 2007-12-31 2013-03-27 Takeda Pharmaceutical Company Limited Kristalline und gelöste Formen von (R)-2-[[[3-methyl-4-(2, 2, 2-trifluorethoxy)-2-pyridinyl-]methyl-]sulfinyl-]-1H-benzoimidazol
AU2009224247B2 (en) * 2008-03-10 2013-12-12 Takeda Pharmaceutical Company Limited Crystal of benzimidazole compound
WO2011004387A2 (en) 2009-06-18 2011-01-13 Matrix Laboratories Ltd Process for the preparation of dexlansoprazole polymorphic forms
WO2011098938A1 (en) * 2010-02-11 2011-08-18 Orchid Chemicals And Pharmaceuticals Limited Novel solvate of dexlansoprazole
WO2012074110A1 (ja) 2010-12-03 2012-06-07 武田薬品工業株式会社 口腔内崩壊錠
US20130273157A1 (en) 2010-12-27 2013-10-17 Takeda Pharmaceutical Company Limited Orally disintegrating tablet
CN102180866B (zh) * 2011-05-23 2013-03-13 中山大学 兰索拉唑晶型及其制备方法和应用
CN103012369B (zh) * 2011-05-23 2014-04-23 中山大学 兰索拉唑n晶型及其制备方法和应用
CA2857457C (en) 2011-11-30 2018-05-01 Takeda Pharmaceutical Company Limited Dry coated tablet
US9119769B2 (en) 2011-12-30 2015-09-01 The Curators Of The University Of Missouri Method for transforming pharmaceutical crystal forms
SG11201509439SA (en) 2013-05-21 2015-12-30 Takeda Pharmaceutical Orally disintegrable tablet
CN103539729A (zh) * 2013-10-14 2014-01-29 安徽国星生物化学有限公司 一种氯甲基吡啶衍生物的工业化生产方法
CN103539728A (zh) * 2013-10-14 2014-01-29 安徽国星生物化学有限公司 一种拉唑类药物中间体氯甲基吡啶衍生物的合成方法
CN104829594A (zh) * 2015-05-15 2015-08-12 苗怡文 一种治疗胃溃疡的药物兰索拉唑化合物
CN104817492B (zh) * 2015-05-22 2018-05-18 抚州三和医药化工有限公司 兰索拉唑中间体2-羟甲基-3-甲基-4-(2,2,2-三氟乙氧基）吡啶的分离纯化方法
KR102649498B1 (ko) 2023-12-06 2024-03-20 거산해운(주) 선사별 실시간 통합 예약 정보를 기반으로 한 화주의 해상 운송 예약 자동화 플랫폼 서비스 제공 방법, 장치 및 시스템

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
DK171989B1 (da) * 1987-08-04 1997-09-08 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
DE4018642C2 (de) * 1990-06-11 1993-11-25 Byk Gulden Lomberg Chem Fab Neue Salzform des 5-Difluormethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl]-1H-benzimitazol-Natriumsalzes
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
US5374730A (en) * 1993-11-04 1994-12-20 Torcan Chemical Ltd. Preparation of omeprazole and lansoprazole
GB2297550C2 (en) * 1995-02-06 1997-04-09 Smithkline Beecham Plc Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
TW385306B (en) * 1996-11-14 2000-03-21 Takeda Chemical Industries Ltd Method for producing crystals of benzimidazole derivatives

Also Published As

Publication number Publication date
IL129724A (en) 2004-02-19
AU731776B2 (en) 2001-04-05
AU4965297A (en) 1998-06-03
ATE240314T1 (de) 2003-05-15
IL129724A0 (en) 2000-02-29
WO1998021201A1 (en) 1998-05-22
CA2269053A1 (en) 1998-05-22
NZ335145A (en) 2000-12-22
CN1237167A (zh) 1999-12-01
TW385306B (en) 2000-03-21
HK1020194A1 (en) 2000-03-31
CN1171885C (zh) 2004-10-20
CA2269053C (en) 2006-07-18
PT944617E (pt) 2003-08-29
EP0944617A1 (de) 1999-09-29
US6002011A (en) 1999-12-14
ID21547A (id) 1999-06-24
ES2199356T3 (es) 2004-02-16
DE69722027T2 (de) 2004-03-25
CN1616457A (zh) 2005-05-18
EP0944617B1 (de) 2003-05-14
TR199901055T2 (xx) 1999-07-21
KR100519576B1 (ko) 2005-10-07
DE69722027D1 (de) 2003-06-18
CN100355749C (zh) 2007-12-19
DK0944617T3 (da) 2003-09-01
KR20000053158A (ko) 2000-08-25

Similar Documents

Publication Publication Date Title
IL129724A0 (en) Crystals of benzimidazole derivatives and their production
HUP9802859A2 (hu) Acil-amino-szalicilsav-amid-származékok és alkalmazásuk peszticidként
DE69534975D1 (de) Verwendung von noribogain derivaten zur behandlung von chemischer abhängigkeit bei säugern
YU46916B (sh) Postupak za dobijanje kalcijum nezavisnih camp inhibitora fosfodiesteraze
ES8202546A1 (es) Metodo de producir derivados de tiazolidina
NZ329374A (en) Tricyclic amide and urea derivatives, preparation thereof
TW368501B (en) 7-(2-aminoethyl)-benzothiazolones
GB2091723B (en) Derivatives of 2-oxoazetidine-1-sulphonic acid
ES8704445A1 (es) Procedimiento de preparar derivados aminicos
IE872588L (en) Compounds
MY109628A (en) An improved proces for the preparation of substituted indoline derivatives
HUT50319A (en) Process for production of new derivatives of buthen carbonic acid and prophene carbonic acid and medical compositions containing them
EA200000484A1 (ru) Способ получения производных тиазолидиндиона
JPS5681578A (en) Novel thioalkyl amide derivative
NO940265L (no) Fremgangsmaate ved fremstilling av svovelholdige karboksyl-syreamider
CY2257B1 (en) Process for preparing galanthamine derivatives by asymmetric reduction
EP0449195A3 (en) Aminobenzene compounds, their production and use
TW328083B (en) New derivatives of β-methoxy acrylic acid, their preparation process and their use as pesticides
PT99280A (pt) Processo de preparacao de derivados do indolo e de composicoes farmaceuticas
HU905000D0 (en) Process for producing compounds suitable for treatment of gastric ulcer
AR246321A1 (es) Nuevos colorantes y procedimiento para su obtencion.
MY105057A (en) A process for preparing naphthalene derivatives
HUP0003024A2 (hu) Eljárás nitro-guanidin-származékok előállítására és az új kiindulási vegyületek
EP0367671A3 (de) Beta-D-phenylthioxyloside, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
GR3002688T3 (en) Thiadiazolylacetamide derivatives, process for the preparation thereof and their use